At the forefront of exciting new research to find better treatment for childhood cancer

The principal aim of the Doernbecher Children’s Hospital Development Therapeutics program is to evaluate novel agents for the treatment of pediatric cancer through early phase clinical trials. We conduct Phase I and Phase II trials of potentially promising new drugs for the treatment of all types of childhood cancer. Doernbecher is one of 21 select institutions in North America who comprise the NCI-funded Children’s Oncology Group Phase I Consortium. Through our participation in COG early … Read More

Charles Keller Laboratory welcomes summer students!

We are thrilled to have such talented high school, college and visiting graduate students this summer. A particular focus is personalized osteosarcoma therapy — you can watch a video of our vision for personalized cancer therapy here. Lara Davis, M.D., the adolescent and young adult (AYA) oncology fellow in our lab, is leading students Claire, Olivia, Melissa and Noah (see bios below) in the effort to develop rapid and reliable ways that children with osteosarcoma … Read More

Doernbecher Children's Hospital

Doernbecher Children’s Hospital


Participation Guidelines

Remember: information you share here is public; it isn't medical advice. Need advice or treatment? Contact your healthcare provider directly. Read our Terms of Use and this disclaimer for details.
wordpress stats plugin